NDAORALFOR SOLUTION, TABLET, FOR SOLUTION
Approved
Dec 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 19h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IDKIT:HP is an oral diagnostic kit containing citric acid anhydrous and 13C-labeled urea used to detect Helicobacter pylori infection via the urea breath test. This non-invasive diagnostic tool helps identify H. pylori presence in patients with suspected gastric infection. The test works by measuring 13CO2 in exhaled breath after oral administration of labeled urea.
LOE Approaching
Moderate competitive pressure (30/100) suggests a stable but maturing diagnostic market with limited growth upside and smaller commercial teams.
Mechanism of Action
Pharmacologic Class:
Helicobacter pylori Diagnostic
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on IDKIT:HP offers limited career growth due to the product's mature, LOE-approaching status and lack of linked job openings. Professionals on this product would focus on maintaining market share and managing competitive erosion rather than innovation or expansion.
Diagnostic Sales RepresentativeProduct Manager
Worked on IDKIT:HP at CooperSurgical? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.